ReviewThe Psychiatric clinics of North America2015
Clinical Advances in Geriatric Psychiatry: A Focus on Prevention of Mood and Cognitive Disorders.
Review in The Psychiatric clinics of North America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Reliability and validity of the Brief Attention and Mood Scale of 7 Items: a self-administered, online assessment.Frontiers in psychology · 2025Article
- Affective Computing for Late-Life Mood and Cognitive Disorders.Frontiers in psychiatry · 2021Review
- Brain health INnovation Diplomacy: a model binding diverse disciplines to manage the promise and perils of technological innovation.International psychogeriatrics · 2020Review
- Emerging Complementary and Integrative Therapies for Geriatric Mental Health.Current treatment options in psychiatry · 2020Review
- Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.Cell metabolism · 2018Review
- Mind-Body Therapies for Late-Life Mental and Cognitive Health.Current psychiatry reports · 2018Review
- An Assessment of the Burden on Polish Caregivers of Patients With Dementia: A Preliminary Study.American journal of Alzheimer's disease and other dementias · 2017Article
- When New Technology is an Answer for Old Problems: The Use of Videoconferencing in Cognitive Aging Assessment.Journal of Alzheimer's disease reports · 2017Article
- The Neural Mechanisms of Meditative Practices: Novel Approaches for Healthy Aging.Current behavioral neuroscience reports · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The world population is aging at a rate unprecedented in human history, placing substantial pressure on health systems across the world along with concurrent rises in chronic diseases. In particular, rates of cognitive disorders and late-life affective disorders are expected to increase. In tandem with aging, there are robust predictions suggesting that rates of age-related cognitive decline and dementia, and geriatric depression, will increase, with serious consequences. Clearly innovative prevention and treatment strategies are needed. This article reviews the latest promising clinical advances that hold promise for assisting the prevention and treatment of depression, cognitive decline, and dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.